SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062910
Filing Date
2023-11-13
Accepted
2023-11-13 16:05:38
Documents
67
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rphm-20230930.htm   iXBRL 10-Q 2393910
2 EX-5.1 rphm-ex5_1.htm EX-5.1 22927
3 EX-10.1 rphm-ex10_1.htm EX-10.1 432454
4 EX-31.1 rphm-ex31_1.htm EX-31.1 18903
5 EX-31.2 rphm-ex31_2.htm EX-31.2 18595
6 EX-32.1 rphm-ex32_1.htm EX-32.1 16674
7 GRAPHIC img27530863_0.jpg GRAPHIC 11204
  Complete submission text file 0000950170-23-062910.txt   8207989

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rphm-20230930.xsd EX-101.SCH 42110
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rphm-20230930_cal.xml EX-101.CAL 35718
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rphm-20230930_pre.xml EX-101.PRE 310246
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rphm-20230930_lab.xml EX-101.LAB 362396
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rphm-20230930_def.xml EX-101.DEF 206110
61 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20230930_htm.xml XML 1232027
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40315 | Film No.: 231398588
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences